HMI-115
also HMI
- Phase 2 (BAY-1158061) · injection · Bayer / Hope Medicine · trial NCT06118866
Experimental antibody that blocks the prolactin receptor
BAY-1158061, also known as HMI-115, is a monoclonal antibody against the prolactin receptor (PRLR) which is under development for the treatment of alopecia and endometriosis. It is taken by long-lasting subcutaneous injection. BAY-1158061 has been reported to promote hair growth in balding stump-tailed macaques. The drug was first described in the scientific literature by 2018. It is under development by Bayer and Hope Medicine. As of June 2025, BAY-1158061 is in phase 2 clinical trials for alopecia and endometriosis. Multiple phase 2 trials have been completed, including trials for both alopecia and endometriosis. The chemical structure of BAY-1158061 does not yet appear to have been disclosed.
Read “BAY-1158061” on Wikipedia · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 1
All on OpenAlex →Posts 20
- PP-405 Phase 2/3 study has begun
- What do we actually know about HMI-115?
- Most Promising Future Hair Loss Treatments In 2026
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
- Now That PP405 Hype is Gone What is Everyone Coping with as the Next Cure?
- hmi115 is coming. Prepare yourselves for what's coming
- What is HMI-115 and is it any good?
- Hope Medicine's HMI-115 could be out in 2027 per Company Founder
- HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer
- What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news
- Hmi-115 hair loss cure, how does it work? Is there a relationship between prolactin and DHT?
- Hope Medicine announces HMI-115 phase II clinical trial for androgenetic alopecia in China
- Interview with ABSCI CEO: Think of this as "The Ozempic of Hair Regrowth".
- Hope Medicine HMI-115 Phase 1 Success in Australia! 14 hairs/cm2 increase in hair growth.
- HLT Megathread on HMI-115 (key takeaways in comments)
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- What is your opinion on HMI-115?
- How can we be ok with lowering DHT by 70% just to keep/regrow hair?
- Is there ANY new medications being worked on?
- Respect to those in the control group